HOMILADORLIK QANDLI DIABETI: XAVF OMILLARI, ONA VA HOMILA UCHUN ASORATLAR, PROFILAKTIKA VA DAVOLASHNING ZAMONAVIY YONDASHUVLARI
Keywords:
homiladorlik qandli diabeti, gestatsion diabet, giperglikemiya, insulin rezistentligi, xavf omillari, makrosomiya, preeklampsiya, neonatal gipoglikemiya, glikemik nazorat, insulinoterapiya, ovqatlanish terapiyasi, glyukozaga tolerantlik testi, perinatal asoratlar, profilaktika, tug‘ruqdan keyingi kuzatuv.Abstract
Homiladorlik qandli diabeti (HQD) homiladorlik davrida birinchi marta aniqlanadigan yoki homiladorlik vaqtida yuzaga kelgan giperglikemiya bilan tavsiflanadigan metabolik buzilish bo‘lib, zamonaviy akusherlik va endokrinologiyaning dolzarb klinik muammolaridan biri hisoblanadi. Mazkur holatning ahamiyati uning nafaqat homiladorlik va tug‘ruq jarayoniga, balki ona hamda bolaning keyingi hayotidagi metabolik salomatligiga ham ta’sir ko‘rsatishi bilan belgilanadi. Homiladorlik davomida platsentar gormonlar ta’sirida insulin rezistentligining fiziologik ravishda ortishi kuzatiladi. Oshqozon osti bezining beta-hujayralari ushbu o‘zgarishlarga yetarli darajada moslasha olmagan hollarda glyukozaning qondagi miqdori oshib, gestatsion diabet rivojlanishi mumkin. Kasallikning shakllanishida ortiqcha vazn, semizlik, irsiy moyillik, oilaviy qandli diabet anamnezi, avvalgi homiladorlikda HQD kuzatilganligi, yirik vaznli chaqaloq tug‘ilishi va ayrim metabolik kasalliklar muhim o‘rin tutadi. Mazkur maqolaning maqsadi homiladorlik qandli diabetining etiopatogenetik mexanizmlari, xavf omillari, diagnostik mezonlari, ona va homila uchun qisqa hamda uzoq muddatli asoratlari, shuningdek, profilaktika va davolashning zamonaviy tamoyillarini ilmiy adabiyotlar asosida tahlil qilishdan iborat. Tadqiqot metodologiyasi sifatida xalqaro klinik tavsiyalar, milliy klinik protokollar, randomizatsiyalangan klinik tadqiqotlar va tizimli sharhlarning narrativ-qiyosiy tahlili qo‘llanildi. Adabiyotlar tahlili HQDni o‘z vaqtida aniqlash va glikemik nazoratni ta’minlash ona hamda homila uchun ayrim noxush perinatal natijalar xavfini kamaytirishda muhim ekanini ko‘rsatadi. Nazorat qilinmagan giperglikemiya homilada ortiqcha o‘sish, makrosomiya, tug‘ruq jarohatlari va neonatal gipoglikemiya ehtimolini oshirishi, onada esa preeklampsiya, tug‘ruqning murakkablashuvi va operativ tug‘ruq ehtimoli bilan bog‘liq bo‘lishi mumkin. Zamonaviy boshqaruv yondashuvi ovqatlanishni individual rejalashtirish, xavfsiz jismoniy faollik, glyukozani muntazam nazorat qilish, zarurat tug‘ilganda insulinoterapiya va tug‘ruqdan keyingi metabolik kuzatuvni o‘z ichiga oladi. Xulosa sifatida homiladorlik qandli diabetini boshqarishda xavfni erta baholash, dalillarga asoslangan diagnostika, individual davolash va tug‘ruqdan keyingi profilaktik kuzatuvni birlashtirgan uzluksiz tibbiy yordam tizimini rivojlantirish zarurligi asoslanadi. го реагирования на безгражданство в XXI веке.
References
1. World Health Organization. WHO Recommendations on Care for Women with Diabetes during Pregnancy. Geneva: World Health Organization; 2025. 76 p. ISBN: 978-92-4-011704-4. Nashriyot: World Health Organization.
2. American Diabetes Association Professional Practice Committee. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl. 1):S321–S338. Nashriyot: American Diabetes Association. DOI: 10.2337/dc26-S015.
3. Respublika ixtisoslashtirilgan ona va bola salomatligi ilmiy-amaliy tibbiyot markazi. Gestatsion qandli diabet: milliy klinik protokol. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi; 2025. Elektron klinik protokol. Nashriyot va tasdiqlash rekvizitlari protokolning titul varag‘i bo‘yicha rasmiylashtiriladi.
4. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. The New England Journal of Medicine. 2008;358:1991–2002. Nashriyot: Massachusetts Medical Society. DOI: 10.1056/NEJMoa0707943.
5. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care. 2010;33(3):676–682. Nashriyot: American Diabetes Association. DOI: 10.2337/dc09-1848.
6. Metzger B.E., Gabbe S.G., Persson B. va boshq. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care. 2010;33(3):676–682. Nashriyot: American Diabetes Association. DOI: 10.2337/dc09-1848.
7. Crowther C.A., Hiller J.E., Moss J.R. va boshq. Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. The New England Journal of Medicine. 2005;352:2477–2486. Nashriyot: Massachusetts Medical Society. DOI: 10.1056/NEJMoa042973.
8. Landon M.B., Spong C.Y., Thom E. va boshq. A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes. The New England Journal of Medicine. 2009;361:1339–1348. Nashriyot: Massachusetts Medical Society. DOI: 10.1056/NEJMoa0902430.
9. Hod M., Kapur A., Sacks D.A. va boshq. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on Gestational Diabetes Mellitus: A Pragmatic Guide for Diagnosis, Management, and Care. International Journal of Gynecology & Obstetrics. 2015;131(Suppl. 3):S173–S211. Nashriyot: Wiley. DOI: 10.1016/S0020-7292(15)30007-2.
10. Erdanov U., Absaitov R., Negmadjanov B.B. Current Data on the Incidence of Gestational Diabetes Mellitus. Central Asian Journal of Academic Research. 2025;3(2):100–103. Nashriyot: Central Asian Journal of Academic Research. DOI: 10.5281/zenodo.14858883.
